
Everything You Need to Know About the Benefits of Light Therapy
Unless you've sworn off social media, you've probably noticed that LED face masks are everywhere recently. Like, I can't go a single day without swiping past at least one Instagram Story of an influencer wearing one. And if you're anything like me (read: always curious about the latest wellness trend), you might be wondering whether light therapy has any actual benefits.
To answer that question, we need to zoom out a little bit. Light therapy—aka phototherapy—isn't just something that exists in the beauty world. It's actually a pretty complicated topic. Light therapy comes in many different forms, and it can be used to treat a whole bunch of different health concerns. In fact, it's been proven to help with everything from mental health to chronic pain and sleep disorders.
Because I have zero medical degrees, I asked five experts who do to explain how light therapy works, what conditions it can help with, and which devices are the best if you're curious about trying it at home. Read on for the scoop.
Since light therapy is used in so many different contexts, it's tough to narrow down just one definition of what it is and how it works. But to keep it really basic, light therapy involves being exposed to specific wavelengths of light to treat a range of mental and physical conditions. It generally uses LED (or light-emitting diode) light, but the exact color of the light, the intensity, and the length of exposure will depend on what you're trying to treat.
Light therapy works in two main ways: It's either applied onto the skin or exposed to the eyes (again, depending on what condition you're dealing with), to change a biological function in the body, explains Mohab Ibrahim, MD, PhD, a professor of anesthesiology at The University of Arizona and medical director of the University's Comprehensive Center for Pain and Addiction. We'll get into more specifics later on what functions and conditions it can help with.
Light therapy can have a lot of benefits. Here, I've outlined five of the most common ways it's used and who might be a good candidate to try it.
If your mood tends to take a nosedive in the fall and winter, you've probably heard of SAD lamps. These are light therapy lamps that simulate natural sunlight, helping your body to decrease production of melatonin (the hormone which regulates your body's sleep-wake cycle) and increase production of serotonin (a hormone which helps regulate mood), explains Amanda White, LPC, LMHC, therapist and founder of Therapy for Women Center.
They're usually called SAD lamps because they're most commonly used to treat seasonal affective disorder (SAD), but light therapy lamps can actually help with all types of depressive disorders, says psychiatrist Seth A. Eappen, MD. A 2024 study published in JAMA Psychiatry found that bright light therapy (another term for light therapy) led to a 41 percent remission rate in people with nonseasonal depression—higher than the remission rate for other treatment methods, like antidepressants, alone. Another benefit is how quickly it can work. Some patients notice improved mood within days, while antidepressants can take weeks to kick in, White adds.
To feel the benefits, Dr. Eappen recommends getting a lamp that emits 10,000 lux and starting with 15-minute sessions every day. You can use the lamp anytime before 2:30 p.m., he says—after that point, it might start to mess with your sleep. Sit with the lamp about 12 inches away from you and avoid looking directly at it. As long as you don't notice any negative effects like headaches, sleep disturbances, or overstimulation, you can keep increasing the length of your sessions by 15 minutes each week until you hit 60 minutes a day, he says.
Good news: It turns out those trendy LED face masks aren't pure snake oil. LED exposure has proven anti-aging benefits.
'Cells in our body respond to [LED light], and the energy they receive [from it] is used to 'refuel' them, giving them new energy to replace old damaged cells with new youthful ones,' explains dermatologist Rachel Nazarian, MD. Benefits include increased collagen production, improved skin elasticity, and reduced pigment unevenness. In other words, with regular use, you can be left with fewer wrinkles, a more even complexion, and plumper skin.
It's important to remember that these benefits come from red LED light specifically, Dr. Nazarian adds. Both at-home and in-office treatments can be effective, but you'll have to be more patient and consistent with an at-home device in order to see results. When shopping for an LED face mask, look for a model that has FDA clearance, meaning it's been shown to be safe and effective. Therabody and Omnilux both make masks that have been FDA-cleared.
Some preliminary research suggests that blue LED light might help clear acne—but it's still early. A 2024 study published in the Journal of Cutaneous Medicine and Surgery found that people with mild to moderate acne saw some improvement in their skin after getting three or more treatments for four weeks straight. But Dr. Nazarian says more research needs to be done before she'd feel comfortable recommending blue light therapy for acne. It's not well understood yet, and there are potential skin damage risks that need to be studied further, she says.
Beyond anti-aging, light therapy has been proven to help with skin conditions like eczema and psoriasis. According to the National Eczema Association, phototherapy can help with itching and inflammation. You'll need to have it prescribed and administered by a derm, though. Similarly, the National Psoriasis Foundation says that phototherapy has been shown to slow the growth of affected cells, in turn reducing symptoms.
Light therapy can also be helpful for certain types of chronic pain. The most well-understood form is red light therapy, which is most commonly used to treat joint pain and arthritis symptoms. Let's say you messed up your knee in a workout class, and now it hurts whenever you walk long distances. Using a red light device directly on your knee can help decrease inflammation, in turn reducing the amount of pain you feel, says Dr. Ibrahim.
According to a 2021 study published in The Journal of Pain, applying red light through the skin—even for just a short period of time—can decrease joint pain, nerve pain, inflammatory pain (think: sprains and strains), and even postsurgical pain. If you want to try it at home, Dr. Ibrahim recommends opting for a device that's been FDA cleared, like the Kineon MOVE+ Pro. Just keep in mind that when it comes to pain relief, there's no one-size-fits-all solution. Similar to how you might respond better to Advil sometimes and Tylenol other times, depending on the specific type of pain you're dealing with, red light therapy isn't a cure-all for physical pain, he adds.
There's also emerging evidence that suggests green light therapy can reduce pain. Unlike red light therapy, which is applied through the skin, green light therapy is applied through the eyes. Based on the research that's been done so far, experts think that green light alters the pain centers in the brain, turning off mechanisms that amplify pain and turning on mechanisms that suppress pain, explains Dr. Ibrahim. So far, studies indicate that it can be helpful for people with conditions like chronic migraines and fibromyalgia.
Since red light therapy can reduce inflammation, it also has potential workout recovery benefits. Muscle soreness often comes with an inflammatory response as the body works to repair the muscles you've just broken down in the gym. It varies from person to person, but applying red light to the area where you're sore might make you feel less achy and help you recover faster, says Dr. Ibrahim.
Research is limited, but a 2016 study published in the Journal of Biophotonics found that using red light therapy and near-infrared light therapy (a slightly different wavelength than red) either before or after a workout can increase overall performance and reduce fatigue and inflammation.
Last but certainly not least, light therapy has proven sleep benefits. That's because light exposure affects the body's circadian rhythm, aka our body's natural sleep-wake cycle. Ideally, your circadian rhythm is synced up to the 24-hour cycle, helping you to wake up when the sun comes up and prepare for sleep when the sun goes down. But sometimes it gets out of whack, making it hard to wake up in the morning or fall asleep at a normal time. Light therapy can help reset your body's 'clock,' says Brandon Peters, MD, a neurologist and sleep medicine specialist.
'Appropriately timed exposure to light will help everyone sleep better,' he explains. He recommends trying to get 15 to 30 minutes of direct sunlight exposure within 15 minutes of waking up. If you're going outside, don't wear a hat or sunglasses, since that can lessen the impact. Exposing yourself to light first thing in the AM will make it easier for you to feel awake and refreshed, and also help you feel a natural desire to go to sleep at night, he says. It can also be beneficial for sleep disorders like insomnia, and situational issues like jet lag.
Another option is a light therapy box. Dr. Peters recommends getting one that has an intensity of at least 10,000 lux of either white or blue light. Sitting in front of it for 15 to 30 minutes in the morning will provide a lot of the same benefits that natural sunlight exposure does.
Here, the answer depends on which benefits you're looking for. If you're after mental health, sleep, or skin benefits, you'll want to do light therapy pretty regularly. For mental health and sleep, make light therapy part of your daily routine, following the time guidelines the experts mentioned above. But when it comes to your skin, you can be a little more lax. Most LED face mask brands recommend that you use them three to five times per week to see results. In terms of how often you should do light therapy treatments for specific skin conditions like eczema, you'll need to talk to your doctor.
If you're interested in light therapy for pain relief or muscle recovery, you can use it on more of an as-needed basis. There's no need to strap on your red light therapy device every day—unless you're experiencing pain on the daily. And if that's the case, it's important to reach out to your doctor to figure out the root of your issue.
Kara Cuzzone is a New York City-based writer, editor, and artist. She has over seven years of experience covering health, wellness, and shopping-related topics for sites including Forbes, Cosmopolitan, Byrdie, Wondermind, and PureWow.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Canadian Nuclear Laboratories and the University of Ottawa Accelerate Low Dose Radiation Research and Foster Next Generation of Scientists
New partnership furthers Canada's international leadership in low dose radiation research CANADIAN NUCLEAR LABORATORIES AND THE UNIVERSITY OF OTTAWA ACCELERATE LOW DOSE RADIATION RESEARCH AND FOSTER NEXT GENERATION OF SCIENTISTS CHALK RIVER, Ontario, June 09, 2025 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada's premier nuclear science and technology organization, and the University of Ottawa (uOttawa), one of Canada's most innovative universities, are pleased to announce a new partnership to advance knowledge, education, research and innovation in low dose radiation (LDR) exposure health effects. Leveraging the leading research organizations' complementary capabilities, the new partnership builds on CNL's global leadership in LDR research with the establishment of a CNL-led LDR innovation hub, accelerating research critical to public safety and the health of Canadians. It will also serve to increase capabilities, education and training opportunities to graduate students and early career researchers. The partnership will also extend uOttawa researchers' access to Atomic Energy of Canada Limited's world class facilities at Chalk River Laboratories, including the unique Biological Research Facility, associated irradiation facilities and LDR Tissue Bank, and establishes a CNL satellite laboratory within uOttawa's new Advanced Medical Research Centre (AMRC) – set to open in 2026. This physical presence will be co-located with the Ottawa Institute of Systems Biology (OISB) as well as uOttawa state-of-the-art Core Facilities, which altogether will support new research directions in radiation sciences and advanced organoid-based systems biology. These areas are rapidly developing strengths at uOttawa, positioning the university as a national, and potentially international, leader in this field. uOttawa will also offer reciprocal access to key research facilities on campus, in addition to those located at the faculty of medicine and in AMRC. 'As a major player in the global research and development effort to support LDR research, CNL is focused on the prevention or reduction of radiation exposure effects in workers, patients and the larger population,' says Dr. Stephen Bushby, Vice-President, Science & Technology, CNL. 'We are very excited to include uOttawa as a major partner in the work needed to shed light on this complex field of research.' As part of this partnership, CNL will be contributing towards the acquisition of a mass spectrometer, which will be installed in the in the Metabolomics Core Facility at uOttawa. This strategic investment, supporting collaborative initiatives between OISB and CNL, will enable leading-edge single-cell metabolomics and spatial metabolomics, a rapidly advancing field with transformative potential in biomedical research. This will be the only equipment of its kind in eastern Canada, offering unique capabilities for high-resolution chemical imaging at the cellular level. The instrument will not only serve researchers at uOttawa, but also attract national and international collaborators, firmly establishing uOttawa as a leader in metabolomics and precision health research. The mass spectrometer will be a central component of the new Spatial Biology and Single-Cell Suite (3S) within the AMRC. This cutting-edge suite will integrate transformative new technologies into a coordinated workflow that complements and enhances five existing and intensively used Core Facilities: Flow Cytometry, Metabolomics, Gene Editing, Cellular Imaging, and Bioinformatics. By bridging these platforms, 3S will significantly expand research capabilities in some of uOttawa's strongest areas of discovery, particularly brain, heart, and cancer biology—driving breakthroughs in systems biology, precision medicine, and therapeutic development. 'This new equipment, the only one of its kind in Eastern Canada, positions the University of Ottawa as a leader in metabolomics and precision health research, while attracting national and international collaborations,' says Julie St-Pierre, Interim Vice-President, Research and Innovation, uOttawa. This new partnership builds on over a decade of collaborative research involving CNL and multiple uOttawa faculties, including Engineering, Science and Medicine. These collaborations have advanced understanding of the biomedical impacts of LDR, including studies on DNA damage and repair, protein synthesis, epigenetics, mitochondrial biology, metabolism, immunity, and stem cell functions. As part of this partnership, CNL has also provided funding support for postdoctoral fellow stipends, further enabling high-impact research and talent development. With the field of LDR research growing and Canadian leadership in LDR research well-recognized, both organizations will continue to explore additional opportunities to further strengthen this partnership. About CNL As Canada's premier nuclear science and technology laboratory and working under the direction of Atomic Energy of Canada Limited (AECL), CNL is a world leader in the development of innovative nuclear science and technology products and services. Guided by an ambitious corporate strategy known as Vision 2030, CNL fulfills three strategic priorities of national importance – restoring and protecting the environment, advancing clean energy technologies, and contributing to the health of Canadians. By leveraging the assets owned by AECL, CNL also serves as the nexus between government, the nuclear industry, the broader private sector and the academic community. CNL works in collaboration with these sectors to advance innovative Canadian products and services towards real-world use, including carbon-free energy, cancer treatments and other therapies, non-proliferation technologies and waste management solutions. To learn more about CNL, please visit About the University of Ottawa The University of Ottawa is powered by research. Located in Canada's capital, we bring together energetic and creative scholars to tackle urgent global challenges and to respond to emerging opportunities. As one of Canada's most innovative universities, we generate breakthroughs and discoveries that make a real difference in communities across Ontario, Canada and the world. Our thought leaders provide evidence-based insights that inform policy and support industry. Our influence keeps growing due to our vast range of international partnerships, including our membership in the U7+ Alliance. As the world's largest French-English university, we are a driving force in the Francophonie. To learn more about uOttawa, please visit CNL Contact:Philip KompassDirector, Corporate Communications1-866-886-2325media@ uOttawa contact:media@ A photo accompanying this announcement is available at
Yahoo
16 hours ago
- Yahoo
Imre Introduces the AI Conversation Converter
Agency launches First-in-Kind platform to quickly insert healthcare brands directly into the AI conversation NEW YORK, June 9, 2025 /PRNewswire/ -- Imre has cracked the GenAI visibility code with the Imre Conversation Converter, a proprietary platform and service that inserts brands directly into the new AI-led customer conversations. "400 million people are now using AI to search and make their decisions,"1 says Haifa Barbari, Imre's EVP of Innovation & Strategy. "Healthcare customers are talking to AI, and they're acting on the answers they get. Our question for brands is, 'Are you even in the conversation?'" The speed of AI adoption is unprecedented. Physicians are embracing AI in record numbers with 66% reporting using AI in their practice, nearly doubling from 38% in 2023.2 "This is a profound landscape change," says Barbari. "It's an understatement to say marketers need to rethink their strategy: They need completely new tools. That's what drove our rapid development and deployment of the Imre Conversation Converter." Imre Conversation Converter is the new DTC—and moreThe Imre Conversation Converter establishes a completely new way to engage healthcare customers-effectively and efficiently-whether the focus is DTC, HCP, caregivers, or all three. While SEO-only brands are increasingly finding themselves shut out of the decision-making dialogue, the Imre Conversation Converter gives marketers the power to: Establish how they're showing up to their customers today; Upgrade the brand's visibility and relevance, with precision targeting of the right customers at key decision moments; and Ensure they stay there. The Imre Conversation Converter begins with an AI Conversation Activation, which scores a brand's current visibility and engagement in the new AI-curated landscape. Then it's time to enhance the brand conversation with strategy and content by uniquely harnessing AI technology channeled through Imre's 32 years of industry insight and expertise. "The Conversation Converter starts with that critical barometer of where the brand stands now," says Barbari, "but the true power comes in giving marketers the ability to take back control of their brand narrative." "AI is fundamentally altering how people search, learn, and make decisions," says Anna Kotis, President of Imre. "With the Conversation Converter, Imre now has the unique power to not only score and track brand visibility, but the power to shape it, and own a brand's relevance in the new customer conversations, delivering smarter engagement with greater ROI." About Imre:Imre is a performance-driven creative agency that connects people to brands for life's most important decisions. With roots 32 years deep in the worlds of digital, social, and PR, Imre is now a full-service agency-of-record (AOR) with an impressive roster of launch and lifecycle brands (including both HCP and DTC), led by a team of seasoned launch experts. Imre's innovative approaches span across creative, brand strategy, omnichannel marketing, AI optimization, influencer, paid media, and the latest in data and analytics. The agency maintains offices in New York, Philadelphia, and Baltimore, and is an LGBTQ-founded company. 1 Reuters, Feb. 20252 American Medical Association, Feb. 2025 View original content to download multimedia: SOURCE Imre 登入存取你的投資組合
Yahoo
21 hours ago
- Yahoo
Ivermectin is now available without a prescription in some places. Good luck finding it.
Boise, Idaho, pharmacist Matt Murray has no choice but to disappoint the handful of people who call him every day asking for a drug used to treat parasitic worms. He could give them the medication, called ivermectin, but only with a doctor's note. The callers aren't in the throes of an active intestinal worm infestation, Murray said. They simply want access to the pills without having to see a doctor first. 'A lot of people are calling, asking, 'Do you guys have it for sale? Can I buy it? How do I get it?'' said Murray, the director of operations for the independent Customedica Pharmacy. 'Not so much, 'How does it work? What is it for?'' The volume of such calls has increased sharply since mid-April, when Idaho Gov. Brad Little, a Republican, signed a bill into law mandating that ivermectin be available to anyone who wants it over the counter. While the law technically says that pharmacists like Murray can sell the drug over the counter, the Food and Drug Administration hasn't approved it to be used this way. 'I don't feel that we could just sell prescription ivermectin,' Murray said. 'It's not designed or packaged for retail sale.' That hasn't stopped frenzied social media claims about ivermectin's supposed 'miraculous' abilities to cure everything from Covid to cancer. 'Ivermectin eliminated the cancer on the skin of my shoulder and it only took 3 weeks,' one person wrote on X. 'It's also working wonders on my eczema,' another wrote on the platform. Ivermectin has never been formulated or labeled specifically for over-the-counter use, like aspirin or an antacid. Without proper guidance, there is concern that people could overdose on the medication. Interest in using drugs or experimental treatments in unapproved ways has gained steam with Robert F. Kennedy Jr.'s appointment as head of the Department of Health and Human Services. Kennedy recently said on a podcast that people should have access to controversial alternative therapies like stem cells and chelation therapy to remove heavy metals from the body. The FDA has warned that neither should be used without oversight from a doctor. The hype has prompted lawmakers in 16 states, including Idaho, to propose and in some cases pass legislation to make the pills readily available for anyone without a prescription. While health insurance covers many prescription drugs, including ivermectin, it doesn't cover over-the-counter medicines. This year, two other GOP-led states — Arkansas and Tennessee — passed over-the-counter ivermectin laws. NBC News called 15 independent pharmacies in those states, plus Idaho, to ask whether pharmacists could provide ivermectin without a prescription. Not a single one said they'd sell the drug over the counter, despite the new laws. All, however, appeared to be sympathetic to the request. One pharmacist in Arkansas took the time to explain that he needed to wait until the FDA provided guidance on over-the-counter ivermectin. Until then, he and all the others said, over-the-counter access to ivermectin would have to wait. Pharmacists say that just because over-the-counter ivermectin is written into law doesn't mean it should be made available to anyone who asks for it. They still rely on federal health guidance. 'Most over-the-counter drugs, especially ones that were prescriptions at one point, go through some FDA approval process,' Murray said. 'In that process, it gets decided what the labeling is going to say,' including warnings and directions. Republican lawmakers in Alabama, Georgia, Kentucky, Louisiana, Maine, Minnesota, Mississippi, New Hampshire, North Carolina, North Dakota, Pennsylvania, South Carolina and West Virginia have also proposed bills to make ivermectin available over the counter. Nearly all would simply permit health care providers and pharmacists to distribute ivermectin without a prescription. Most, like the one proposed in Alabama, would also protect pharmacists from any possible disciplinary action such as fines or license suspension from pharmacy licensing boards for dispensing it. Maine's proposed legislation specifically permits ivermectin to be sold to people who want to try it for Covid, cancer or the flu. Mississippi's bill would limit over-the-counter ivermectin to anyone 18 and older. The drug likely wouldn't be placed on store shelves, but be kept behind pharmacy counters, much like some cold medicines. Even if states do pass laws protecting pharmacists from disciplinary action, like the proposed legislation in Alabama, Murray said that he and his colleagues remain concerned. 'If you dispense something that doesn't have directions or safety precautions on it, who's ultimately liable if that causes harm?' Murray said. 'I don't know that I would want to assume that risk.' The Food and Drug Administration warns that taking large doses of ivermectin 'can be dangerous' and cause vomiting, diarrhea, low blood pressure, seizures, coma and even death. The drug could also interact with other medications like blood thinners, the FDA says. A spokeswoman for CVS Health said that while its pharmacies are able to dispense ivermectin with a prescription, they are 'not currently selling ivermectin over the counter' in any state. Walgreens declined to comment. Ivermectin was discovered by Japanese biochemist Satoshi Ōmura in the 1970s, first as a veterinary drug and then as a groundbreaking treatment for dangerous and disfiguring tropical diseases such as river blindness, as well as tapeworms, scabies and other worm-related infections. Hundreds of millions of people in mostly underdeveloped countries have used it safely with minimal side effects, such as fatigue or diarrhea, for decades. During the pandemic, the true benefit of the drug got twisted and distorted amid a social media frenzy. When mainstream doctors and scientists insisted that ivermectin didn't treat Covid, mostly conservative groups embraced it in direct opposition to public health officials. Podcaster Joe Rogan told his tens of millions of followers that ivermectin worked to cure him of Covid in 2021, prompting many people to seek out the drug as a way to treat mild or moderate cases of the virus. While there was early hope that ivermectin could ease Covid symptoms, it didn't treat respiratory viruses. It still doesn't. Ivermectin has also been touted as a cancer cure. On the same podcast, actor Mel Gibson claimed ivermectin had wiped out Stage 4 cancer in three of his friends. Gibson offered no proof. Some cancer patients believed the promises, with potentially devastating results. 'I tried that last year,' Scott Adams, the creator of the 'Dilbert' comic strip, wrote on X, 'to no effect.' Adams, a vocal Donald Trump supporter, revealed in May that he'd been diagnosed with advanced prostate cancer. 'There are claims of it working, but I am aware of no patient who benefitted from it.' Adams asked his social media followers to stop inundating him with advice to take ivermectin. Adams wrote that his 'odds of survival have probably jumped from zero to 30%' because he decided on a different treatment and will be 'working with top doctors in the field.' When one person pleaded with him in the comments not to discourage people from trying ivermectin, the cartoonist didn't play around: 'Your advice could kill people if they delay other treatments.' There's simply no evidence that ivermectin treats cancer, said Dr. Harold Burstein, a breast oncologist at Dana-Farber Cancer Institute in Boston. He knows because he's looked for it, without success. Since the Rogan podcast featuring Gibson aired, Burstein has had an uptick in patients asking him about ivermectin. He scoured the medical literature looking for any shred of indication that the drug could be useful to his patients. 'There are exactly zero published clinical trials in a human being on whether ivermectin does or doesn't treat cancer,' Burstein said. 'I can assure you that if any oncologist in America had seen' a benefit to ivermectin, he said, 'they would have been eager to write it up.' Some scientists are indeed trying to figure out whether ivermectin has any impact on cancer outcomes. Researchers at Cedars-Sinai Medical Center in Los Angeles have begun a preliminary study combining ivermectin with an immunotherapy drug for patients with metastatic triple-negative breast cancer. Final results aren't expected anytime soon. Ivermectin is manufactured in the U.S. by Merck. The company said in a statement that ivermectin should only be used within the approved FDA framework. 'The use of ivermectin is not supported beyond the doses and populations indicated in the regulatory agency-approved prescribing information,' a Merck spokesperson wrote in an email. Despite the growing push for over-the-counter ivermectin, there's no sales data available for how many people are buying the pills. Focusing on making ivermectin available without a doctor's prescription is the latest in a trend of mostly conservative politicians sidestepping expert medical advice. Utah and Florida, for example, recently banned community water fluoridation, despite decades of widespread evidence that it drastically reduces tooth decay. Dr. Hugh Cassiere, director of critical care services for South Shore University Hospital, part of Northwell Health in New York, said, 'This is about constituents who either heard, read or saw something on social media and now have an idea that this is something good. They're going right to their congressman or senator to demand access.' 'That's not how medicine should work,' he said. Scientists did, in fact, study whether ivermectin helped people with Covid. Dr. Adrian Hernandez, a cardiologist with the Duke Clinical Research Institute in Durham, North Carolina, led a large research project that ultimately showed ivermectin had no benefit in treating acute Covid. 'It's always great that legislators care about the health of the state,' Hernandez said. 'But ivermectin didn't help patients get better any faster.' Hernandez's study was posted on a preprint server called medRxiv in 2022. Studies posted on the site are considered preliminary because they haven't been peer-reviewed. A second 2022 paper published by the New England Journal of Medicine found that Covid patients treated with ivermectin weren't any less likely to be hospitalized than people who didn't get the drug. A third study that did suggest a benefit was later retracted because it contained fraudulent data, according to the publisher. None of this stopped many from demanding access to the drug. During the pandemic, hospitals reported a spike in patients who had been poisoned after taking veterinary-grade ivermectin intended for livestock. Two deaths in New Mexico were linked to the drug. Even the FDA warned that high doses of ivermectin can cause seizures, coma and death. 'You are not a horse. You are not a cow. Seriously, y'all. Stop it,' the FDA tweeted on Aug. 21, 2021. The controversial post was later deleted but can still be accessed through web archives. A Merck spokesperson said the drug shouldn't be used for anything other than clearing parasitic infestations. Northwell Health's Cassiere said medications, especially ivermectin, should only be used after talking with a qualified health care provider, no matter how politicians vote. 'If you're not an expert, if you did not go to medical school, nurse practitioner school, physician assistant school, and don't have the proper training, then you should not be recommending therapies outside of that expertise,' he said. 'Are you going to get a bank loan at the deli on the corner? I don't think so.' This article was originally published on